CD8A and diabetes mellitus: CD8+ CD122hi Ly49+ cells were discovered in young naïve mice [92, 93], EAE models [92, 94, 95], colitis [96, 97], hepatitis [98], arthritis [99], diabetes [100, 101], viral infection [102], tumor immunity [103], atherogenesis [104], and organ transplantation [105].